Teva Pharmaceuticals Says Generic Version Of Forteo Approved In U.S

UroGen Pharma Files Patent Infringement Lawsuit Against Teva Pharma

Biotech company UroGen Pharma Ltd. (URGN) announced Wednesday that it has filed a lawsuit in the U.S. District Court for the District of Delaware against Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd. (TEVA), alleging infringement of U.S. Patent Numbers 9,040,074 and 9,950,069.

RTTNews | 406 дней спустя

Teva Pharma Guides FY24 Revenue Above Estimates; Intends To Divest API Business - Update

While reporting financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) initiated its adjusted earnings and revenue guidance for the full-year 2024.

RTTNews | 469 дней спустя

Teva Pharma Boosts FY23 Revenue Outlook - Update

While reporting financial results for the third quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed its adjusted earnings guidance for the full-year 2023, while raising annual revenue outlook.

RTTNews | 553 дней спустя

Teva Pharma Boosts FY23 Revenue Outlook - Update

While reporting financial results for the second quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed its adjusted earnings guidance for the full-year 2023, while raising annual revenue outlook.

RTTNews | 651 дней спустя

Teva Pharma Reaffirms FY23 Outlook - Update

While reporting financial results for the first quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) reaffirmed its adjusted earnings and revenue guidance for the full-year 2023.

RTTNews | 735 дней спустя

Teva Recalls FENTANYL Buccal Tablets CII

Teva Pharmaceuticals USA is recalling specific lots of various strengths of FENTANYL Buccal Tablets CII to the consumer level citing a labeling error, the U.S. Food and Drug Administration said. The recall has been initiated because safety updates were omitted in the product insert/medication guide that are provided with these recalled lots.

RTTNews | 745 дней спустя

Teva Pharmaceutical Appoints Eric Hughes As Chief Medical Officer

Teva Pharmaceutical Industries Ltd. (TEVA) announced Friday the appointment of Dr. Eric Hughes, MD, PhD as Executive Vice President, Global R&D and Chief Medical Officer. Hughes will begin his employment on August 1, 2022, and will be based out of Teva's U.S. headquarters in Parsippany, New Jersey.

RTTNews | 1048 дней спустя

European Economic News Preview: UK GDP & Foreign Trade Data Due

First quarterly GDP estimates and foreign trade from the UK and flash GDP and employment from the euro area are the major reports due on Thursday. At 2.00 am ET, the Office for National Statistics publishes UK GDP, industrial output and foreign trade figures. The economy is expected to remain flat on month in March after expanding 0.5 percent in February.

RTTNews | 26 минут назад

EURUSD	1.11977	GBPUSD	1.32784	AUDUSD	0.64297
USDJPY	145.951	USDCAD	1.39717	USDCHF	0.83997

Advertisement

Teva Pharmaceuticals Says Generic Version Of Forteo Approved In U.S